A new study by researchers at Duke University reports an abnormality in visual regions of the brain that is associated with a person’s general risk for mental illness. The findings, published in Biological Psychiatry, indicate a signature abnormality shared between common forms of mental illness, which could help clinicians assess a patient’s general risk for developing a mental illness. The signature abnormality was present in participants involved in the study who already had a higher risk of mental illness. This was characterized by a reduced efficiency between visual areas and brain networks important for integrating sensory information and suppressing distracting information.
Researchers have long thought that some aspects of the biology of the risk for psychiatric disorders were specific to particular disorders, and by studying specific groups of patients, may have mistaken general risk factors as specific risk factors. Newer research suggests that a person’s risk for developing mental illness is not specific to one form of disorder, but is instead shared across many different disorders. “In other words, there may be a single risk factor that predicts whether an individual develops any form of psychiatric disorder, be it depression, post-traumatic stress disorder, addiction, or even schizophrenia,” said first author Maxwell Elliott, a doctoral student in the laboratory of Ahmad Hariri, PhD.
Researchers have found a way to scan electronic health records (EHRs) that helps identify associations between broad dimensions of behavioral function and genes relevant to mental disorders. Use of the technique opens an enormous source of data to researchers who are interested in taking a dimensional approach to the study of mental illnesses instead of using traditional diagnostic categories. The study, funded in part by the National Institute of Mental Health (NIMH), was published online February 26, 2018 in the journal Biological Psychiatry.
As medicine has entered the digital age, the use of electronic systems for managing health data has skyrocketed. These electronic health records provide a trove of information for researchers who want to understand factors that contribute to health and illness.
Mental illness has long had a stigma associated it, and Hollywood is working to shine a light on the problem, both for those in and out of the entertainment industry.
Kita S. Curry has made a career of studying mental health as president and CEO of Didi Hirsch Mental Health Services, the nation’s leading provider of community health and substance use programs. Curry spoke to Variety about the struggle many actors and musicians have with depression and substance abuse, due both to their hectic schedules and dealings with fame.
“I think that when you become well known, it’s hard to know if people like you or like your halo,” she said. “If you are depressed and already feel like you’re a failure, you never live up, it’s hard for people to understand the dark voices that can tell us what losers we are when people seem to successful.”
Stopping exercise can result in increased depressive symptoms, according to new mental health research from the University of Adelaide.
PhD student Julie Morgan from the University of Adelaide’s Discipline of Psychiatry has reviewed the results of earlier studies that examined the effects of stopping exercise in regularly active adults.
The results of her review are now published online ahead of print in the Journal of Affective Disorders.
“Adequate physical activity and exercise are important for both physical and mental health,” says Ms Morgan.
Nikolas Cruz, the 19-year-old whose alleged shooting rampage claimed 17 lives at Marjory Stoneman Douglas High School in Parkland, Fla., last month, was sick. His family knew it. His neighbors knew it. Local law enforcement and mental-health professionals knew it.
Yet, like so many tragedies involving the seriously mentally ill, no one was able to prevent the rampage. Why?
As the family member of someone with serious mental illness, and as someone who has spent 30 years helping other families with seriously ill members, the answer is clear: The system often prevents relatives from getting help for loved ones who have serious mental illness until after they have become a danger to themselves or others. Too often this means after someone — often a family member — is injured or killed.
Amid the outcry over the Florida school shooting, the Trump administration says it is “actively exploring” ways to help states expand inpatient mental health treatment using Medicaid funds.
President Donald Trump again brought up the issue of mental hospitals in a meeting with governors on Monday, invoking a time when states maintained facilities for mentally ill and developmentally disabled people.
“In the old days, you would put him into a mental institution,” Mr. Trump said, apparently referring to alleged shooter Nikolas Cruz, whose troubling behavior prompted people close to him to plead for help from authorities, without success. “We’re going to have to start talking about mental institutions …we have nothing between a prison and leaving him at his house, which we can’t do anymore.”
In an analysis of one of the largest electronic medical records databases in the world, researchers found that patients with acne had a significantly increased risk of developing major depression, but only in the first 5 years after being diagnosed with acne.
The British Journal of Dermatology analysis included data from The Health Improvement Network (THIN) (1986-2012), a large primary care database in the United Kingdom.
The investigators found that the risk for major depression was highest within 1 year of acne diagnosis — a 63% higher risk compared with individuals without acne — and decreased thereafter.
Antipsychotic drugs — which transformed mental health care following their chance discovery in the mid-20th Century — may finally be poised for a long-overdue makeover incorporating structure-based design. Scientists funded by the National Institutes of Health have achieved a landmark of psychiatric neuropharmacology: deciphering the molecular structure of a widely prescribed antipsychotic docked in its key receptor. They are hopeful that this discovery may hold secrets to designing better treatments for schizophrenia, bipolar disorder, and other mental illnesses.
“For the first time, we can understand precisely how atypical antipsychotic drugs bind to their primary molecular target in the human brain,” explained Dr. Laurie Nadler, chief of the neuropharmacology program at the National Institute of Mental Health (NIMH), which co-funded the study along with the National Institute of General Medical Sciences and the National Cancer Institute. “This discovery opens the way for the rational design of a new generation of antipsychotic drugs, hopefully with more desirable effects and fewer side effects.”
Feelings of shame may make the symptoms of post-traumatic stress disorder (PTSD) more severe in current and former members of the Armed Services.
That is the conclusion of research published in the British Journal of Clinical Psychology by a team led by Dr Katherine C. Cunningham from the Department of Veterans Affairs Mid-Atlantic Mental Illness Research, Education and Clinical Center, Durham, North Carolina.
In the forthcoming article, Dr Cunningham and colleagues say, “The military conflicts in Iraq and Afghanistan have resulted in increased awareness of the impact of war on military service members. Many returning service members and veterans have been diagnosed with PTSD, which is associated with poorer physical health, unemployment, legal problems, relationship conflict and reduced quality of life.”
A week after the government announced its review of mental health legislation, an expert report published by the British Psychological Society’s Division of Clinical Psychology on Friday 13 October challenges received wisdom about the nature of mental illness.
The report, Understanding Psychosis and Schizophrenia: Why people sometimes hear voices, believe things that others find strange or appear out of touch with reality, and what can help, has been written by a group of eminent clinical psychologists drawn from eight universities and six NHS trusts, together with people who have themselves experienced psychosis. It provides an accessible overview of the current state of knowledge, and its conclusions have profound implications both for the way we understand ‘mental illness’ and for the future of mental health services.
Many people believe that schizophrenia is a frightening brain disease that makes people unpredictable and potentially violent, and can only be controlled by medication. However this report — a revised version of one published in 2014 by the British Psychological Society’s Division of Clinical Psychology — suggests that this view is false.